Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.

[1]  E. Garrafa,et al.  Profile of toll-like receptors on peripheral blood cells in relation to acute graft-versus-host disease after allogeneic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[2]  B. Sawitzki,et al.  Tregs: application for solid-organ transplantation , 2012, Current opinion in organ transplantation.

[3]  D. Heo,et al.  CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function , 2012, Tumor Biology.

[4]  S. Kim,et al.  B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy , 2012, Leukemia & lymphoma.

[5]  J. Klein,et al.  Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. , 2011, The Lancet. Oncology.

[6]  Ruth R. Montgomery,et al.  Age-associated elevation in TLR5 leads to increased inflammatory responses in the elderly , 2011, Aging cell.

[7]  S. Smeekens,et al.  The classical CD14++CD16− monocytes, but not the patrolling CD14+CD16+ monocytes, promote Th17 responses to Candida albicans , 2011, European journal of immunology.

[8]  A. Gratwohl,et al.  Lymphocyte subset recovery and outcome after T-cell replete allogeneic hematopoietic SCT , 2011, Bone Marrow Transplantation.

[9]  R. Negrin,et al.  Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. , 2011, Blood.

[10]  B. Storer,et al.  Activation and expansion of CD8(+) T effector cells in patients with chronic graft-versus-host disease. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[11]  S. Scholl,et al.  Reconstitution and functional analyses of neutrophils and distinct subsets of monocytes after allogeneic stem cell transplantation , 2011, Journal of Cancer Research and Clinical Oncology.

[12]  C. Meisel,et al.  Differential Expression and Function of &agr;-Mannosidase I in Stimulated Naive and Memory CD4+ T Cells , 2011, Journal of immunotherapy.

[13]  K. Messer,et al.  CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  Magda R Hamczyk,et al.  Rapid Decrease of CD16 (FcγRIII) Expression on Heat-Shocked Neutrophils and Their Recognition by Macrophages , 2011, Journal of biomedicine & biotechnology.

[15]  B. Molnár,et al.  Peripheral Blood Based Discrimination of Ulcerative Colitis and Crohn’s Disease from Non-IBD Colitis by Genome-Wide Gene Expression Profiling , 2011, Disease markers.

[16]  J. Ritz,et al.  Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease. , 2011, Blood.

[17]  A. Fanning,et al.  Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome , 2011, The American Journal of Gastroenterology.

[18]  Y. Bertrand,et al.  Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children , 2011, British journal of haematology.

[19]  J. Wagner,et al.  Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics. , 2011, Blood.

[20]  M. Mayes,et al.  Whole-blood Gene Expression Profiling in Ankylosing Spondylitis Shows Upregulation of Toll-like Receptor 4 and 5 , 2011, The Journal of Rheumatology.

[21]  J. Schatzle,et al.  Cutting Edge: The Adapters EAT-2A and -2B Are Positive Regulators of CD244- and CD84-Dependent NK Cell Functions in the C57BL/6 Mouse , 2010, The Journal of Immunology.

[22]  J. Passweg,et al.  CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells , 2010, European journal of immunology.

[23]  M. Netea,et al.  Diversity: a hallmark of monocyte society. , 2010, Immunity.

[24]  J. Casanova,et al.  Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.

[25]  J. Wagner,et al.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.

[26]  Graham M Lord,et al.  Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.

[27]  M. Suthanthiran,et al.  Identification of a B cell signature associated with renal transplant tolerance in humans. , 2010, The Journal of clinical investigation.

[28]  H. Einsele,et al.  Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. , 2010, Blood.

[29]  D. Heo,et al.  Abstract LB-328: Granulocytic myeloid-derived suppressor cells that have suppressive function: CD15+/CD16lowhuman granulocytes from advanced cancer patients , 2010 .

[30]  J. Wingard,et al.  Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. , 2010, Blood.

[31]  Y. Hildebrandt,et al.  Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44+) and T (HLA-DR+) cells , 2010, Bone Marrow Transplantation.

[32]  S. Latour,et al.  Essential function for SAP family adaptors in the surveillance of hematopoietic cells by natural killer cells , 2009, Nature Immunology.

[33]  M. Triggiani,et al.  Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes , 2009, European journal of immunology.

[34]  J. Ritz,et al.  Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease. , 2009, Blood.

[35]  K. Akashi,et al.  T Cell Leukemia/Lymphoma 1 and Galectin-1 Regulate Survival/Cell Death Pathways in Human Naive and IgM+ Memory B Cells through Altering Balances in Bcl-2 Family Proteins1 , 2009, The Journal of Immunology.

[36]  Y. Pekarsky,et al.  Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL , 2008, Proceedings of the National Academy of Sciences.

[37]  P. Lavori,et al.  Sirolimus and Mycophenolate Mofetil as Graft-versus-Host Disease Prophylaxis in Myeloablative, Matched Related Donor Hematopoietic Cell Transplantation , 2008, Bone Marrow Transplantation.

[38]  Hiroshi Kiyono,et al.  Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5 , 2008, Nature Immunology.

[39]  Song-Cheol Kim,et al.  Effect of immunosuppressants on the expansion and function of naturally occurring regulatory T cells. , 2007, Transplant immunology.

[40]  H. Volk,et al.  Identification of Gene Markers for the Prediction of Allograft Rejection or Permanent Acceptance , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  Christopher H Contag,et al.  Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. , 2006, Blood.

[42]  H. Koenen,et al.  Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells. , 2006, Blood.

[43]  C. Geczy,et al.  Circulating CD10−/CD16low neutrophils provide a quantitative index of active bone marrow neutrophil release , 2005, British journal of haematology.

[44]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[45]  M. Rosso,et al.  Detection of CD16low neutrophil subpopulations , 2003, Cytometry. Part B, Clinical cytometry.

[46]  S. Cole,et al.  Novel orphanin FQ/nociceptin transcripts are expressed in human immune cells , 2002, Journal of Neuroimmunology.

[47]  H. Ziegler-Heitbrock,et al.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. , 1996, Immunology today.

[48]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Hogg,et al.  Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. , 1994, Journal of immunology.

[50]  S. Paczesny,et al.  Clinical applications for biomarkers of acute and chronic graft-versus-host disease. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  M. Cooper,et al.  Immunoregulatory roles for fc receptor-like molecules. , 2011, Current topics in microbiology and immunology.

[52]  N. Smits,et al.  Anticoagulant heparan sulfate to not clot--or not? , 2010, Progress in molecular biology and translational science.

[53]  M. Cooper,et al.  Fc receptor-like proteins (FCRL): immunomodulators of B cell function. , 2007, Advances in experimental medicine and biology.